Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04803357 · ClinicalTrials.gov registry record · NA
A Study on the Use of Real -Time Continuous Glucose Monitoring (RT-CGM) in Gestational Diabetes
A NA study of Gestational Diabetes, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
- 1
- Study location
NCT04803357 is a NA study of Gestational Diabetes that has completed, run by University of Washington. The registered enrollment target is 105 participants, below the 319-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04803357, a NA study of Gestational Diabetes, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine whether RT-CGM (real time continuous glucose monitoring) use improves glucose control, maternal outcomes, and fetal outcomes in patients diagnosed with gestational diabetes. Currently, there is very limited data on whether RT-CGM use helps patients diagnosed with gestational diabetes. By conducting this study, the investigator hopes to develop a deeper understanding of how use of a RT-CGM may affect glucose control in the gestational diabetes population.
Conditions Studied
Interventions
- DEVICE Continuous glucose monitor
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2021-04-10 |
| Est. Completion | 2025-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04803357
The ClinicalTrials.gov registry entry for NCT04803357 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 319-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (67% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gestational Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Continuous glucose monitor is the first listed.
NCT04803357 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT04803357 about?
NCT04803357 is a clinical study titled "A Study on the Use of Real -Time Continuous Glucose Monitoring (RT-CGM) in Gestational Diabetes". The purpose of this study is to examine whether RT-CGM (real time continuous glucose monitoring) use improves glucose control, maternal outcomes, and fetal outcomes in patients diagnosed with gestational diabetes. Currently, there is very limited data on whether RT-CGM use helps patients diagnosed w...
What is the current status of trial NCT04803357?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2021-04-10. Estimated completion is 2025-01-15.
What conditions does trial NCT04803357 study?
This clinical trial studies the following conditions: Gestational Diabetes.
What interventions are being tested in trial NCT04803357?
The interventions under investigation include: Continuous glucose monitor (DEVICE).
Who is sponsoring clinical trial NCT04803357?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04803357 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Nutrition Optimization and Community Upliftment for Postpartum Recovery
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
RECRUITING · NA
-
Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.